Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Differences between bacteria grown in vitro and in vivo.

× No keyword cloud information.

14 in total

Review 1. Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.

Authors: R C Li; M Zhu; J J Schentag
Journal: Clin Pharmacokinet Date: 1999-07 Impact factor: 6.447

2. Minimum antibiotic levels for selecting a resistance plasmid in a gnotobiotic animal model.

Authors: D E Corpet; S Lumeau; F Corpet
Journal: Antimicrob Agents Chemother Date: 1989-04 Impact factor: 5.191

3. Pharmacodynamic modeling of ciprofloxacin resistance in Staphylococcus aureus.

Authors: Jeffrey J Campion; Patrick J McNamara; Martin E Evans
Journal: Antimicrob Agents Chemother Date: 2005-01 Impact factor: 5.191

Review 4. Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies.

Authors: M R Brown; P J Collier; P Gilbert
Journal: Antimicrob Agents Chemother Date: 1990-09 Impact factor: 5.191

5. Penetration of ciprofloxacin into human lung tissue following intravenous injection.

Authors: D Schlenkhoff; A Dalhoff; J Knopf; W Opferkuch
Journal: Infection Date: 1986 Nov-Dec Impact factor: 3.553

Review 6. Alternative strategies for proof-of-principle studies of antibacterial agents.

Authors: Axel Dalhoff; Andrej Weintraub; Carl Erik Nord
Journal: Antimicrob Agents Chemother Date: 2014-05-27 Impact factor: 5.191

7. Aeromonas salmonicida Growth in Response to Atlantic Salmon Mucins Differs between Epithelial Sites, Is Governed by Sialylated and N-Acetylhexosamine-Containing O-Glycans, and Is Affected by Ca².

Authors: János Tamás Padra; Henrik Sundh; Kristina Sundell; Vignesh Venkatakrishnan; Chunsheng Jin; Tore Samuelsson; Niclas G Karlsson; Sara K Lindén
Journal: Infect Immun Date: 2017-07-19 Impact factor: 3.441

Differences between bacteria grown in vitro and in vivo.

Review 1. Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.

2. Minimum antibiotic levels for selecting a resistance plasmid in a gnotobiotic animal model.

3. Pharmacodynamic modeling of ciprofloxacin resistance in Staphylococcus aureus.

Review 4. Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies.

5. Penetration of ciprofloxacin into human lung tissue following intravenous injection.

Review 6. Alternative strategies for proof-of-principle studies of antibacterial agents.

7. Aeromonas salmonicida Growth in Response to Atlantic Salmon Mucins Differs between Epithelial Sites, Is Governed by Sialylated and N-Acetylhexosamine-Containing O-Glycans, and Is Affected by Ca².

Review 8. Pathogenicity and virulence: another view.

Review 9. In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB.

10. Prolonged growth of a clinical Staphylococcus aureus strain selects for a stable small-colony-variant cell type.

Differences between bacteria grown in vitro and in vivo.

Review 1. Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.

2. Minimum antibiotic levels for selecting a resistance plasmid in a gnotobiotic animal model.

3. Pharmacodynamic modeling of ciprofloxacin resistance in Staphylococcus aureus.

Review 4. Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies.

5. Penetration of ciprofloxacin into human lung tissue following intravenous injection.

Review 6. Alternative strategies for proof-of-principle studies of antibacterial agents.

7. Aeromonas salmonicida Growth in Response to Atlantic Salmon Mucins Differs between Epithelial Sites, Is Governed by Sialylated and N-Acetylhexosamine-Containing O-Glycans, and Is Affected by Ca2.

Review 8. Pathogenicity and virulence: another view.

Review 9. In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB.

10. Prolonged growth of a clinical Staphylococcus aureus strain selects for a stable small-colony-variant cell type.

7. Aeromonas salmonicida Growth in Response to Atlantic Salmon Mucins Differs between Epithelial Sites, Is Governed by Sialylated and N-Acetylhexosamine-Containing O-Glycans, and Is Affected by Ca².